Biomedical Advanced Research and Development Authority (original) (raw)
La Biomedical Advanced Research and Development Authority (BARDA, traduït com Autoritat de Recerca i Desenvolupament Biomèdic Avançat) és una oficina del Departament de Salut i Serveis Humans dels Estats Units responsable de l'adquisició i el desenvolupament de contramesures mèdiques, principalment contra el bioterrorisme, incloses les amenaces químiques, biològiques, radiològiques i nuclears, a més de la pandèmia de grip i malalties emergents.
| Property | Value |
|---|---|
| dbo:abstract | هيئة البحث والتطوير الطبي الحيوي هي مكتب تابع لوزارة الصحة والخدمات الإنسانية في الولايات المتحدة ، وهو مسؤول عن شراء وتطوير التدابير المضادة بشكل أساسي ضد الإرهاب البيولوجي ، ولكن يشمل أيضًا التهديدات الكيميائية والنووية والإشعاعية وكذلك الأنفلونزا الوبائية والأمراض الناشئة. تقدم تقاريرها إلى مكتب السكرتير المساعد للاستعداد والاستجابة وتدير مشروع بيوشيلد . تقوم أيضًا بشراء المواد، مثل اللقاحات، للمخزون الاستراتيجي الوطني، وعلى نطاق أوسع هي واجهة ثابتة بين حكومة الولايات المتحدة والصناعة الطبية الحيوية . تدير أيضًا مؤسسة التدابير الطبية الطارئة الحكومية المشتركة بين الوكالات الحكومية، حيث توفر التنسيق عبر الحكومة في تطوير ونشر هذه التدابير المضادة. أنشأ قانون مشروع لعام 2004 طريقة لتمويل البحث والتطوير وتخزين اللقاحات والعلاجات التي يمكن أن تستخدمها الحكومة في حالات الطوارئ الصحية العامة مثل الهجمات الكيميائية أو البيولوجية أو الإشعاعية أو النووية. تقدم الوكالة الأموال لشركات الأدوية لتطوير هذه التدابير المضادة. حتى الآن، ساعدت في الحصول على 52 منتجًا معتمدة من إدارة الغذاء والدواء. أنشئ المكتب في عام 2006 من خلال قانون التأهب لمواجهة جميع الأمراض . (ar) La Biomedical Advanced Research and Development Authority (BARDA, traduït com Autoritat de Recerca i Desenvolupament Biomèdic Avançat) és una oficina del Departament de Salut i Serveis Humans dels Estats Units responsable de l'adquisició i el desenvolupament de contramesures mèdiques, principalment contra el bioterrorisme, incloses les amenaces químiques, biològiques, radiològiques i nuclears, a més de la pandèmia de grip i malalties emergents. (ca) The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks. In addition to preparing and maintaining bioterrorism responses and countermeasures, HHS, through the ASPR and BARDA, prepares and maintains an integrated system of medical countermeasures for both known or unknown, and re-emerging or novel types of public health emergencies. These include diagnostic tools, therapeutics, such as antibiotics and antivirals, and preventative measures, such as vaccines. BARDA is an established, official interface between the U.S. federal government and the biomedical industry. BARDA also participates in the governmental inter-agency Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), providing coordination across the US federal government in developing and deploying such countermeasures. BARDA works with the biomedical industry, using grants and other assistance, to promote advanced research, innovation and the development of medical devices, tests, vaccines and therapeutics. BARDA also procures and maintains stockpiles of materials, such as drugs, personal protective equipment (PPE) and vaccines, for the Strategic National Stockpile (SNS). (en) Die Biomedical Advanced Research and Development Authority (BARDA) ist eine Behörde des Ministeriums für Gesundheitspflege und Soziale Dienste der Vereinigten Staaten (HHS), das für die Beschaffung und Entwicklung medizinischer Gegenmaßnahmen zuständig ist, hauptsächlich gegen Bioterrorismus, einschließlich chemischer, biologischer, radiologischer und nuklearer Bedrohungen. sowie pandemische Influenza und neu auftretende Krankheiten. Die Behörde verwaltet das Projekt , das die Forschung, Entwicklung und Bevorratung von Impfstoffen und Behandlungen finanziert, die die Regierung bei Notfällen im Bereich der öffentlichen Gesundheit wie chemischen, biologischen, radiologischen oder nuklearen Angriffen einsetzen kann. Dazu gehören diagnostische Instrumente, Therapeutika wie Antibiotika und Virostatika. BARDA ist eine etablierte, offizielle Schnittstelle zwischen der US-Bundesregierung und der biomedizinischen Industrie. BARDA beteiligt sich auch am staatlichen behördenübergreifenden Unternehmen für öffentliche medizinische Notfallmaßnahmen , das die Koordination zwischen den US-Bundesregierungen bei der Entwicklung und dem Einsatz solcher Gegenmaßnahmen gewährleistet. BARDA beschafft und unterhält Lagerbestände an Materialien wie Arzneimitteln, persönlicher Schutzausrüstung (PSA) und Impfstoffen für den (SNS). (de) La Biomedical Advanced Research and Development Authority (BARDA) est un bureau du département de la Santé et des Services sociaux des États-Unis (HHS) chargé de l'acquisition et du développement de contre-mesures médicales, principalement contre le bioterrorisme, y compris les menaces nucléaires, radiologiques, biologiques et chimiques (NRBC), ainsi que les pandémies (grippe pandémique et pandémie de COVID-19 notamment) et les maladies émergentes . La BARDA relève du (ASPR) et gère le . (fr) アメリカ生物医学先端研究開発局（アメリカせいぶついがくせんたんけんきゅうかいはつきょく、英語: Biomedical Advanced Research and Development Authority、略称：BARDA）は、アメリカ合衆国保健福祉省の一部局で、アメリカ国内に公衆衛生上の危機が生じることが予見される際に、必要なワクチン、医薬品、治療法などの開発、購入するための支援を行う機関である。アメリカ国内外の研究機関、医薬品会社などへの資金提供、複数の研究機関の橋渡し役などを担う。2010年代から2020年代にかけては、急性放射線症候群、エボラ出血熱、新型コロナウイルス感染症 (2019年)などへのアプローチを行ってきた。 (ja) De Biomedical Advanced Research and Development Authority (Overheidsdienst voor fundamenteel biomedisch onderzoek en ontwikkeling, BARDA) is een afdeling van het Amerikaans ministerie van Volksgezondheid die verantwoordelijk is voor de levering en ontwikkeling van medische voorzieningen tegen enerzijds bioterrorisme en NBC-wapens, en anderzijds pandemieën en opkomende ziekten. BARDA werd opgericht door een pandemiewet uit 2006, en ressorteert onder de staatssecretaris voor rampenbestrijding. Het bureau beheert Project BioShield, een programma voor noodsituaties van biomedische aard. Het agentschap vormt ook de officiële brug tussen de Amerikaanse federale overheid en de biomedische industrie. Het verstrekt subsidies en andere hulp om geavanceerd onderzoek, innovatie en de ontwikkeling van medische hulpmiddelen, tests, vaccins en therapeutica te bevorderen. BARDA levert en onderhoudt ook de strategische voorraden aan medicijnen, persoonlijke beschermingsmiddelen (PBM) en vaccins. (nl) Il Biomedical Advanced Research and Development Authority (BARDA) è un ufficio del Dipartimento della salute e dei servizi umani (HHS) degli Stati Uniti responsabile dell'approvvigionamento e dello sviluppo di contromisure mediche , principalmente contro il bioterrorismo , comprese le minacce chimiche, biologiche, radiologiche e nucleari (CBRN), così come l'influenza pandemica e le malattie emergenti. Il BARDA è stato istituito nel 2006 attraverso il Pandemic and All-Hazards Preparedness Act (PAHPA) e fa capo all'Ufficio del Segretario aggiunto per la preparazione e la risposta (ASPR). L'ufficio gestisce il Progetto BioShield, che finanzia la ricerca, lo sviluppo e lo stoccaggio di vaccini e trattamenti che il governo potrebbe utilizzare durante emergenze di salute pubblica come attacchi chimici, biologici, radiologici o nucleari (CBRN). Il BARDA collabora con l'industria biomedica, utilizzando sovvenzioni e altre forme di assistenza, per promuovere la ricerca avanzata, l'innovazione e lo sviluppo di dispositivi medici, test, vaccini e terapie. Inoltre si procura e mantiene scorte di materiali, come farmaci, dispositivi di protezione individuale (DPI) e vaccini, per lo Strategic National Stockpile (SNS). (it) |
| dbo:budget | 1.6E9 (dbd:usDollar) |
| dbo:formationYear | 2006-01-01 (xsd:gYear) |
| dbo:headquarter | dbr:Hubert_H._Humphrey_Building |
| dbo:jurisdiction | dbr:Federal_Government_of_the_United_States |
| dbo:location | dbr:Hubert_H._Humphrey_Building |
| dbo:numberOfEmployees | 150 (xsd:nonNegativeInteger) |
| dbo:parentOrganisation | dbr:Office_of_the_Assistant_Secretary_for_Preparedness_and_Response |
| dbo:thumbnail | wiki-commons:Special:FilePath/Barda_Logo.png?width=300 |
| dbo:wikiPageExternalLink | https://www.medicalcountermeasures.gov/barda https://www.phe.gov/about/pages/default.aspx https://www.medicalcountermeasures.gov/ https://www.medicalcountermeasures.gov/barda/cbrn |
| dbo:wikiPageID | 20003855 (xsd:integer) |
| dbo:wikiPageLength | 50851 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1124706171 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Cangene dbr:Project_Bioshield_Act dbr:Public_Health_Emergency_Medical_Countermeasures_Enterprise dbr:Public_Health_Security_and_Bioterrorism_Preparedness_and_Response_Act dbr:Public_Health_Service_Act dbr:Sanofi_Pasteur dbr:Basilea_Pharmaceutica dbr:Biomedicine dbr:Blood_plasma dbr:Botulinum_toxin dbr:Botulism dbr:Democratic_Republic_of_the_Congo dbr:Hubert_H._Humphrey_Building dbr:Pfizer dbr:Rick_Bright dbr:Robert_Kadlec dbr:Cytokine dbr:United_States_Congress dbr:United_States_Department_of_Defense dbr:United_States_Department_of_Health_and_Human_Services dbr:United_States_Office_of_Special_Counsel dbr:United_States_dollar dbr:United_States_dollars dbr:University_of_Oxford dbr:VX_(nerve_agent) dbr:Vaxart dbr:Defense_Threat_Reduction_Agency dbr:Business_accelerator dbr:SIGA_Technologies dbr:Elusys_Therapeutics dbc:Counterterrorism_in_the_United_States dbr:Cipla dbr:Emergent_BioSolutions dbr:Fujifilm dbr:Gepotidacin dbr:GlaxoSmithKline dbr:Moderna dbr:Anthrax dbr:Anthrax_immune_globulin dbr:Anthrax_vaccine_adsorbed dbr:Staphylococcus_aureus dbr:Zika_virus dbr:Emergency_Use_Authorization dbr:Emergency_department dbr:2001_anthrax_attacks dbr:COVID-19 dbr:COVID-19_pandemic_in_the_United_States dbc:Administration_for_Strategic_Preparedness_and_Response dbr:Ceftobiprole dbr:Centers_for_Disease_Control_and_Prevention dbr:Whistleblower_Protection_Act dbr:Point-of-care_testing dbc:2006_establishments_in_the_United_States dbr:DARPA dbr:Dr._Rick_Bright dbr:Eravacycline dbr:Federal_Government_of_the_United_States dbr:Food_and_Drug_Administration dbr:North_Korea dbr:Pandemic_and_All-Hazards_Preparedness_Reauthorization_Act_of_2013 dbr:Pandemic_and_All-Hazards_Preparedness_Act dbr:Smallpox dbr:Tebipenem dbr:Tecovirimat dbr:AstraZeneca dbr:Kim_Jong-un dbr:Bioterrorism dbr:Ebola dbr:CBRN_defense dbr:Plazomicin dbr:Public_Health_Emergency_(United_States) dbr:Intensive_care_unit dbr:Kivu_Ebola_epidemic dbr:Anthrax_Vaccine_Adsorbed dbr:Merck_&_Co. dbr:Meridian_Medical_Technologies dbr:Midazolam dbr:National_Institute_of_Allergy_and_Infectious_Diseases dbr:National_Institutes_of_Health dbr:Obiltoxaximab dbr:Office_of_Inspector_General,_U.S._Department_of_Health_and_Human_Services dbr:Office_of_the_Assistant_Secretary_for_Preparedness_and_Response dbr:Operation_Warp_Speed dbr:September_11_attacks dbr:World_Health_Organization dbr:Multiple_drug_resistance dbr:Strategic_National_Stockpile dbr:Venture_capital dbr:Executive_order dbr:Public_Health_Security_and_Bioterrorism_Preparedness_Response_Act dbr:Pandemic_and_All-Hazards_Preparedness_and_Advancing_Innovation_Act dbr:Tara_O'Toole dbr:Medical_countermeasure dbr:West_Africa_Ebola_virus_epidemic dbr:Variola_virus dbr:Assistant_Secretary_for_Preparedness_and_Response dbr:Janssen_Pharmaceutical dbr:RVSV-ZEBOV dbr:Project_BioShield dbr:Inovio dbr:Antibiotic-resistant_bacteria dbr:Zaire_ebola_virus dbr:AV7909 dbr:Achaogen dbr:Altimmune dbr:BioFactura dbr:BioProtection_Systems dbr:Heptavalent_Botulism_Antitoxin dbr:Lumos_Pharma dbr:NasoShield dbr:NewLink_Genetics dbr:Pfenex dbr:Px563L dbr:Spero_Therapeutics dbr:Tetraphase_Pharmaceuticals |
| dbp:agencyName | Biomedical Advanced Research and Development Authority (en) |
| dbp:budget | $1.6 billion USD (en) |
| dbp:chief1Name | Gary Disbrow (en) |
| dbp:chief1Position | Acting Director (en) |
| dbp:employees | 150 (xsd:integer) |
| dbp:formed | December 2006 (en) |
| dbp:headquarters | Hubert H. Humphrey Building, Washington, D.C. (en) |
| dbp:jurisdiction | dbr:Federal_Government_of_the_United_States |
| dbp:logo | File:Barda Logo.png (en) |
| dbp:parentAgency | dbr:Office_of_the_Assistant_Secretary_for_Preparedness_and_Response |
| dbp:website | https://www.medicalcountermeasures.gov/barda |
| dbp:wikiPageUsesTemplate | dbt:Authority_control dbt:Bulleted_list dbt:Nbsp dbt:POV dbt:Rp dbt:See_also dbt:Short_description dbt:Undisclosed_paid dbt:Unsourced_section dbt:Infobox_government_agency dbt:United_States_research_agencies dbt:U.S._biological_defense |
| dct:subject | dbc:Counterterrorism_in_the_United_States dbc:Administration_for_Strategic_Preparedness_and_Response dbc:2006_establishments_in_the_United_States |
| rdf:type | owl:Thing schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q327333 wikidata:Q43229 dbo:GovernmentAgency dbo:Organisation |
| rdfs:comment | La Biomedical Advanced Research and Development Authority (BARDA, traduït com Autoritat de Recerca i Desenvolupament Biomèdic Avançat) és una oficina del Departament de Salut i Serveis Humans dels Estats Units responsable de l'adquisició i el desenvolupament de contramesures mèdiques, principalment contra el bioterrorisme, incloses les amenaces químiques, biològiques, radiològiques i nuclears, a més de la pandèmia de grip i malalties emergents. (ca) La Biomedical Advanced Research and Development Authority (BARDA) est un bureau du département de la Santé et des Services sociaux des États-Unis (HHS) chargé de l'acquisition et du développement de contre-mesures médicales, principalement contre le bioterrorisme, y compris les menaces nucléaires, radiologiques, biologiques et chimiques (NRBC), ainsi que les pandémies (grippe pandémique et pandémie de COVID-19 notamment) et les maladies émergentes . La BARDA relève du (ASPR) et gère le . (fr) アメリカ生物医学先端研究開発局（アメリカせいぶついがくせんたんけんきゅうかいはつきょく、英語: Biomedical Advanced Research and Development Authority、略称：BARDA）は、アメリカ合衆国保健福祉省の一部局で、アメリカ国内に公衆衛生上の危機が生じることが予見される際に、必要なワクチン、医薬品、治療法などの開発、購入するための支援を行う機関である。アメリカ国内外の研究機関、医薬品会社などへの資金提供、複数の研究機関の橋渡し役などを担う。2010年代から2020年代にかけては、急性放射線症候群、エボラ出血熱、新型コロナウイルス感染症 (2019年)などへのアプローチを行ってきた。 (ja) هيئة البحث والتطوير الطبي الحيوي هي مكتب تابع لوزارة الصحة والخدمات الإنسانية في الولايات المتحدة ، وهو مسؤول عن شراء وتطوير التدابير المضادة بشكل أساسي ضد الإرهاب البيولوجي ، ولكن يشمل أيضًا التهديدات الكيميائية والنووية والإشعاعية وكذلك الأنفلونزا الوبائية والأمراض الناشئة. تقدم تقاريرها إلى مكتب السكرتير المساعد للاستعداد والاستجابة وتدير مشروع بيوشيلد . تقوم أيضًا بشراء المواد، مثل اللقاحات، للمخزون الاستراتيجي الوطني، وعلى نطاق أوسع هي واجهة ثابتة بين حكومة الولايات المتحدة والصناعة الطبية الحيوية . تدير أيضًا مؤسسة التدابير الطبية الطارئة الحكومية المشتركة بين الوكالات الحكومية، حيث توفر التنسيق عبر الحكومة في تطوير ونشر هذه التدابير المضادة. (ar) Die Biomedical Advanced Research and Development Authority (BARDA) ist eine Behörde des Ministeriums für Gesundheitspflege und Soziale Dienste der Vereinigten Staaten (HHS), das für die Beschaffung und Entwicklung medizinischer Gegenmaßnahmen zuständig ist, hauptsächlich gegen Bioterrorismus, einschließlich chemischer, biologischer, radiologischer und nuklearer Bedrohungen. sowie pandemische Influenza und neu auftretende Krankheiten. Die Behörde verwaltet das Projekt , das die Forschung, Entwicklung und Bevorratung von Impfstoffen und Behandlungen finanziert, die die Regierung bei Notfällen im Bereich der öffentlichen Gesundheit wie chemischen, biologischen, radiologischen oder nuklearen Angriffen einsetzen kann. Dazu gehören diagnostische Instrumente, Therapeutika wie Antibiotika und Viro (de) The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks. (en) Il Biomedical Advanced Research and Development Authority (BARDA) è un ufficio del Dipartimento della salute e dei servizi umani (HHS) degli Stati Uniti responsabile dell'approvvigionamento e dello sviluppo di contromisure mediche , principalmente contro il bioterrorismo , comprese le minacce chimiche, biologiche, radiologiche e nucleari (CBRN), così come l'influenza pandemica e le malattie emergenti. (it) De Biomedical Advanced Research and Development Authority (Overheidsdienst voor fundamenteel biomedisch onderzoek en ontwikkeling, BARDA) is een afdeling van het Amerikaans ministerie van Volksgezondheid die verantwoordelijk is voor de levering en ontwikkeling van medische voorzieningen tegen enerzijds bioterrorisme en NBC-wapens, en anderzijds pandemieën en opkomende ziekten. BARDA werd opgericht door een pandemiewet uit 2006, en ressorteert onder de staatssecretaris voor rampenbestrijding. Het bureau beheert Project BioShield, een programma voor noodsituaties van biomedische aard. (nl) |
| rdfs:label | Biomedical Advanced Research and Development Authority (en) هيئة البحث والتطوير الطبي الحيوي المتقدم (ar) Autoritat de Recerca i Desenvolupament Biomèdic Avançat dels Estats Units (ca) Biomedical Advanced Research and Development Authority (de) Biomedical Advanced Research and Development Authority (it) Biomedical Advanced Research and Development Authority (fr) アメリカ生物医学先端研究開発局 (ja) Biomedical Advanced Research and Development Authority (nl) |
| rdfs:seeAlso | dbr:COVID-19_vaccine_clinical_research dbr:Authorization_status |
| owl:sameAs | freebase:Biomedical Advanced Research and Development Authority http://viaf.org/viaf/249890460 wikidata:Biomedical Advanced Research and Development Authority dbpedia-ar:Biomedical Advanced Research and Development Authority http://bn.dbpedia.org/resource/বায়োমেডিক্যাল_অ্যাডভান্সড_রিসার্চ_অ্যান্ড_ডেভেলপমেন্ট_অথোরিটি dbpedia-ca:Biomedical Advanced Research and Development Authority dbpedia-de:Biomedical Advanced Research and Development Authority dbpedia-fr:Biomedical Advanced Research and Development Authority dbpedia-it:Biomedical Advanced Research and Development Authority dbpedia-ja:Biomedical Advanced Research and Development Authority dbpedia-nl:Biomedical Advanced Research and Development Authority https://global.dbpedia.org/id/4Ywwm |
| skos:closeMatch | http://www.grid.ac/institutes/grid.476870.a |
| prov:wasDerivedFrom | wikipedia-en:Biomedical_Advanced_Research_and_Development_Authority?oldid=1124706171&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/Barda_Logo.png |
| foaf:homepage | https://www.medicalcountermeasures.gov/barda |
| foaf:isPrimaryTopicOf | wikipedia-en:Biomedical_Advanced_Research_and_Development_Authority |
| foaf:name | Biomedical Advanced Research and Development Authority (en) |
| is dbo:wikiPageRedirects of | dbr:BARDA dbr:Biomedical_advanced_research_and_development_authority dbr:Biomedical_Advanced_Research_and_Development_Agency |
| is dbo:wikiPageWikiLink of | dbr:Cangene dbr:Project_Bioshield_Act dbr:List_of_United_States_federal_research_and_development_agencies dbr:List_of_acronyms:_B dbr:List_of_federal_agencies_in_the_United_States dbr:Production_of_antibiotics dbr:Brett_Giroir dbr:Debra_Katz dbr:Alliance_for_Biosecurity dbr:Johnson_&_Johnson dbr:List_of_COVID-19_vaccine_authorizations dbr:Rick_Bright dbr:Robert_Kadlec dbr:Ventilator dbr:Prestige_Ameritech dbr:Covidien dbr:SIGA_Technologies dbr:Timeline_of_the_2022_monkeypox_outbreak dbr:Coalition_for_Epidemic_Preparedness_Innovations dbr:Emergent_BioSolutions dbr:Grand_River_Aseptic_Manufacturing dbr:Moderna_COVID-19_vaccine dbr:Anthrax_immune_globulin dbr:Anthrax_vaccine_adsorbed dbr:Locus_Biosciences dbr:Chloroquine_and_hydroxychloroquine_during_the_COVID-19_pandemic dbr:Strengthening_Public_Health_Emergency_Response_Act_of_2015 dbr:ZMapp dbr:Empatica dbr:Avita_Medical dbr:BARDA dbr:COVID-19_Advisory_Board dbr:COVID-19_vaccination_in_Singapore dbr:COVID-19_vaccine dbr:Administration_for_Strategic_Preparedness_and_Response dbr:List_of_Auburn_University_people dbr:2022_monkeypox_outbreak_in_the_United_States dbr:Foundation_for_the_National_Institutes_of_Health dbr:Pandemic_and_All-Hazards_Preparedness_Reauthorization_Act_of_2013 dbr:Biomedical_advanced_research_and_development_authority dbr:Golden_LEAF_Biomanufacturing_Training_and_Education_Center dbr:History_of_COVID-19_vaccine_development dbr:List_of_Department_of_Health_and_Human_Services_appointments_by_Donald_Trump dbr:Richard_Hatchett dbr:Pandemic_and_All-Hazards_Preparedness_Act dbr:Ridgeback_Biotherapeutics dbr:Janssen_COVID-19_vaccine dbr:Janssen_Pharmaceuticals dbr:Jim_O'Neill_(investor) dbr:U.S._federal_government_response_to_the_COVID-19_pandemic dbr:Atoltivimab/maftivimab/odesivimab dbr:Biosecurity_in_the_United_States dbr:Bipartisan_Commission_on_Biodefense dbr:Sylvia_Mathews_Burwell dbr:Ebola_vaccine dbr:Heptavalent_botulism_antitoxin dbr:Mark_Olshaker dbr:CARB-X dbr:Influenza_A_virus_subtype_H7N9 dbr:Operation_Warp_Speed dbr:Regeneron_Pharmaceuticals dbr:List_of_whistleblowers dbr:NCBioImpact dbr:National_Biodefense_Strategy dbr:United_States_biological_defense_program dbr:Responses_to_the_COVID-19_pandemic_in_May_2020 dbr:Pandemic_and_All-Hazards_Preparedness_and_Advancing_Innovation_Act dbr:Wake_Forest_Institute_for_Regenerative_Medicine dbr:Thrombocytopenia dbr:Biomedical_Advanced_Research_and_Development_Agency |
| is dbp:agenciesaffected of | dbr:Strengthening_Public_Health_Emergency_Response_Act_of_2015 |
| is foaf:primaryTopic of | wikipedia-en:Biomedical_Advanced_Research_and_Development_Authority |
